-
Eye On the Cure Research News
Foundation Invests $5.5 Million in Seven New Translational Research Projects
-
Eye On the Cure Research News
Bionic Sight Doses First Patient in Clinical Trial for Optogenetic Therapy
-
Eye On the Cure Research News
ProQR’s RNA Therapy for USH2A Performs Well in Phase 1/2 Clinical Trial
-
Beacon Stories
-
Eye On the Cure Research News
Foundation’s No-Cost Program Increased Genetic Testing Rates for IRD Patients

Our Track Record
The Foundation is committed to finding treatments and cures for people affected by blinding retinal diseases.
-
1st gene therapy
for any inherited disease to be approved by the FDA
learn more -
$816M dollars raised
since 1971
learn more -
35 VisionWalk events
throughout the United States
learn more -
82 grants awarded
in 2020 – over 90 investigators, 67 institutions
Learn more
The Foundation in the News
Foundation Invests $5.5 Million in Seven New Translational Research Projects
-
Mar 30, 2021 Eye On the Cure Research News
Bionic Sight’s Optogenetic Therapy Enables Blind Patients to Detect Light and Motion in Early Trial
-
Mar 24, 2021 Eye On the Cure Research News
ProQR’s RNA Therapy for USH2A Performs Well in Phase 1/2 Clinical Trial
-
Mar 22, 2021 Beacon Stories

Living with vision loss can be difficult, but you don't have to do it alone
View local chaptersGet Involved
-
Take important steps toward a cure by participating in a 5k VisionWalk
Join a Walk -
Join people coming together to find a cure from all over the country
Search Our Events -
Make a difference today and support promising research by donating a one-time gift
Donate Now